These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30526453)

  • 1. Mechanistic Insights of Soluble Uric Acid-related Kidney Disease.
    Pan J; Shi M; Ma L; Fu P
    Curr Med Chem; 2020; 27(30):5056-5066. PubMed ID: 30526453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to target uric acid to retard CKD progression.
    Kumagai T; Ota T; Tamura Y; Chang WX; Shibata S; Uchida S
    Clin Exp Nephrol; 2017 Apr; 21(2):182-192. PubMed ID: 27339448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic insights into hyperuricemia-associated renal abnormalities with special emphasis on epithelial-to-mesenchymal transition: Pathologic implications and putative pharmacologic targets.
    Balakumar P; Alqahtani A; Khan NA; Mahadevan N; Dhanaraj SA
    Pharmacol Res; 2020 Nov; 161():105209. PubMed ID: 32979505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Effects of Hyperuricemia.
    Méndez Landa CE
    Contrib Nephrol; 2018; 192():8-16. PubMed ID: 29393089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review.
    Jalal DI
    Curr Med Res Opin; 2016 Nov; 32(11):1863-1869. PubMed ID: 27470664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment of renal function in patients with newly diagnosed hypertension - the role of hyperuricemia as a risk factor for chronic kidney disease - preliminary study.
    Komendarek-Kowalska M
    Pol Merkur Lekarski; 2017 May; 42(251):193-196. PubMed ID: 28557965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for uric acid in the progression of renal disease.
    Kang DH; Nakagawa T; Feng L; Watanabe S; Han L; Mazzali M; Truong L; Harris R; Johnson RJ
    J Am Soc Nephrol; 2002 Dec; 13(12):2888-97. PubMed ID: 12444207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid--a uremic toxin?
    Nakagawa T; Mazzali M; Kang DH; Sánchez-Lozada LG; Herrera-Acosta J; Johnson RJ
    Blood Purif; 2006; 24(1):67-70. PubMed ID: 16361844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid causes kidney injury through inducing fibroblast expansion, Endothelin-1 expression, and inflammation.
    Romi MM; Arfian N; Tranggono U; Setyaningsih WAW; Sari DCR
    BMC Nephrol; 2017 Oct; 18(1):326. PubMed ID: 29089036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of uric acid dysregulation on the kidney.
    Dissanayake LV; Spires DR; Palygin O; Staruschenko A
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1252-F1257. PubMed ID: 32223309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of hyperuricemia and gout in kidney and cardiovascular disease.
    Edwards NL
    Cleve Clin J Med; 2008 Jul; 75 Suppl 5():S13-6. PubMed ID: 18822470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with gout differ from healthy subjects in renal response to changes in serum uric acid.
    Liu S; Perez-Ruiz F; Miner JN
    Joint Bone Spine; 2017 Mar; 84(2):183-188. PubMed ID: 27324603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research Advances in the Mechanisms of Hyperuricemia-Induced Renal Injury.
    Su HY; Yang C; Liang D; Liu HF
    Biomed Res Int; 2020; 2020():5817348. PubMed ID: 32685502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children.
    Özalp Kızılay D; Şen S; Ersoy B
    J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):262-269. PubMed ID: 30759960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic insights of soluble uric acid-induced insulin resistance: Insulin signaling and beyond.
    Yu W; Xie D; Yamamoto T; Koyama H; Cheng J
    Rev Endocr Metab Disord; 2023 Apr; 24(2):327-343. PubMed ID: 36715824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.
    Johnson RJ; Kivlighn SD; Kim YG; Suga S; Fogo AB
    Am J Kidney Dis; 1999 Feb; 33(2):225-34. PubMed ID: 10023633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease.
    Kang DH; Nakagawa T
    Semin Nephrol; 2005 Jan; 25(1):43-9. PubMed ID: 15660334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum uric acid levels in kidney transplant recipients: A cause for concern? A review of recent literature.
    Imasuen UJ; Swanson KJ; Parajuli S
    Transplant Rev (Orlando); 2023 Jul; 37(3):100775. PubMed ID: 37437509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperuricemia and its related histopathological features on renal biopsy.
    Fan S; Zhang P; Wang AY; Wang X; Wang L; Li G; Hong D
    BMC Nephrol; 2019 Mar; 20(1):95. PubMed ID: 30885171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.
    Rodenbach KE; Schneider MF; Furth SL; Moxey-Mims MM; Mitsnefes MM; Weaver DJ; Warady BA; Schwartz GJ
    Am J Kidney Dis; 2015 Dec; 66(6):984-92. PubMed ID: 26209544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.